期刊论文

Qin, L.;Dai, A.-G.

英文

Biomedicine & Pharmacotherapy

0753-3322

2023

158

114177

10.1016/j.biopha.2022.114177

This work was supported by the National Natural Science Foundation of China (No. 81774130 , 81570052 , 81270118 , 81973668 and 82274159 ) and the Youth Program of the National Natural Science Foundation of China (No. 82200066 ). This research is also financially supported by the Natural Science Foundation of Hunan Province (No. 2021JJ30017 , 2022JJ80088 and 2022JJ40308 ), the Postdoctoral Foundation of China (No. 2021M690982 ), the Postgraduate Scientific Research Innovation Project of Hunan Province (No. CX20220823 ), the Scientific Research Project of Changsha Science and Technology Bureau (No. kq2004060 and kq2202272 ), Open Fund Project for the Cultivation Base of National Key Laboratory Jointly Constructed by the Ministry and the Ministry of Traditional Chinese Medicine Powder and Innovative Drugs (No. 21PTKF1001 and 21PTKF1004 ), Key Projects of Hunan Provincial Health Commission ( 202213055529 ) and the Key Project of the Educational Department of Hunan Province (No. 20A375 and 21A0226 ). We thank Home for Researchers editorial team ( www.home-for-researchers.com ) for improving the English language in this manuscript.

本校为第一机构

Evidence is mounting that abnormal vascular remodeling leads to many cardiovascular diseases (CVDs). This suggests that vascular remodeling can be a crucial target for the prevention and treatment of CVDs. Recently, celastrol, an active ingredient of the broadly used Chinese herb Tripterygium wilfordii Hook F, has attracted extensive interest for its proven potential to improve vascular remodeling. Substantial evidence has shown that celastrol improves vascular remodeling by ameliorating inflammation, hyperproliferation, and migration of vascular smooth muscle cells, vascular calcification, en...